SCHEMBL6483177

SCHEMBL6483177

CCCc1cn(C)c2c(=O)[nH]c(-c3cc(S(=O)(=O)N4CCC(CC(=O)O)CC4)ccc3OCC)nc12

nearest known ligand 0.83

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE5A O76074 20/20 0.83
HDAC1 Q13547 1/20 0.61
HDAC2 Q92769 1/20 0.61
HDAC6 Q9UBN7 1/20 0.61
PDE3B Q13370 2/20 0.58
PDE3A Q14432 2/20 0.58
ABCC4 O15439 2/20 0.58
PDE2A O00408 1/20 0.58
ABCC5 O15440 1/20 0.58
PDE6D O43924 1/20 0.58
PDE8A O60658 1/20 0.58
PDE9A O76083 1/20 0.58
ABCB11 O95342 1/20 0.58
CYP3A4 P08684 1/20 0.58
HTR1A P08908 1/20 0.58
PDE6A P16499 1/20 0.58
PDE6G P18545 1/20 0.58
PDE4A P27815 1/20 0.58
ADORA2A P29274 1/20 0.58
ADORA1 P30542 1/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6477495 0.95 PDE5A (0.78) PDE5APDE3BPDE3A
SCHEMBL6475468 0.93 PDE5A (0.85) PDE5AHDAC1HDAC2HDAC6PDE3B
SCHEMBL6643381 0.93 PDE5A (0.81) PDE5AHDAC1HDAC2HDAC6PDE3B
SCHEMBL6642932 0.92 PDE5A (0.81) PDE5AHDAC1HDAC2HDAC6PDE3B
SCHEMBL6641140 0.91 PDE5A (0.81) PDE5AHDAC1HDAC2HDAC6PDE3B
SCHEMBL22028347 0.91 PDE5A (1.00) PDE5AHDAC1HDAC2HDAC6PDE3B
SCHEMBL7055096 0.89 PDE5A (0.76) PDE5AHDAC1HDAC2HDAC6PDE3B
SCHEMBL6639075 0.89 PDE5A (0.86) PDE5AHDAC1HDAC2HDAC6PDE3B
SCHEMBL6643698 0.89 PDE5A (0.83) PDE5AHDAC1HDAC2HDAC6PDE3B
SCHEMBL6641062 0.89 PDE5A (0.75) PDE5APDE3BPDE3A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9271916-B2 Composition for reducing skin wrinkles including PDE5 inhibitor SK CHEMICALS CO., LTD. (KR) 2016-03-01 US claimed
US-20140187775-A1 COMPOSITION FOR REDUCING SKIN WRINKLES INCLUDING PDE5 INHIBITOR SK CHEMICALS CO., LTD. (KR) 2014-07-03 US claimed
WO-2013036081-A2 COMPOSITION FOR REDUCING SKIN WRINKLES INCLUDING PDE5 INHIBITOR SK CHEMICALS CO., LTD. (KR) 2013-03-14 WO claimed
US-6962911-B2 Pyrrolopyrimidinone derivatives, process of preparation and use SK CHEMICALS CO., LTD. (KR) 2005-11-08 US claimed
EP-1257553-B1 PYRROLOPYRIMIDINONE DERIVATIVES, PROCESS OF PREPARATION AND USE SK CHEMICALS CO LTD (KR) 2004-05-26 EP claimed
US-9271916-B2 Composition for reducing skin wrinkles including PDE5 inhibitor SK CHEMICALS CO., LTD. (KR) 2016-03-01 US disclosed
US-20140187775-A1 COMPOSITION FOR REDUCING SKIN WRINKLES INCLUDING PDE5 INHIBITOR SK CHEMICALS CO., LTD. (KR) 2014-07-03 US disclosed
WO-2013036081-A2 COMPOSITION FOR REDUCING SKIN WRINKLES INCLUDING PDE5 INHIBITOR SK CHEMICALS CO., LTD. (KR) 2013-03-14 WO disclosed
EP-1257553-B1 PYRROLOPYRIMIDINONE DERIVATIVES, PROCESS OF PREPARATION AND USE SK CHEMICALS CO LTD (KR) 2004-05-26 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140187775-A1 COMPOSITION FOR REDUCING SKIN WRINKLES INCLUDING PDE5 INHIBITOR PDE5A, PDE3B, PDE3A PDE5A 1/4885HDAC1 467/4885HDAC2 1188/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.